Alzheimer Disease
Showing NaN - NaN of 48
Healthy, Alzheimer Trial in Australia, United Kingdom, United States (AL002, Saline Solution)
Completed
- Healthy
- Alzheimer Disease
- AL002
- Saline Solution
-
Delray Beach, Florida
- +5 more
Dec 7, 2020
Alzheimer Trial in Canada, United States (Flortaucipir F18, Brain PET Scan)
Completed
- Alzheimer Disease
- Flortaucipir F18
- Brain PET Scan
-
San Diego, California
- +9 more
Aug 7, 2020
Alzheimer Trial in United States (Flortaucipir F18, Brain PET Scan)
Completed
- Alzheimer Disease
- Flortaucipir F18
- Brain PET Scan
-
Irvine, California
- +8 more
Aug 7, 2020
Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))
Completed
- Alzheimer Disease
- lecozotan SR (SRA-333)
-
Phoenix, Arizona
- +82 more
Jul 1, 2020
Alzheimer Trial in Japan, United States (LY3002813, Placebo)
Completed
- Alzheimer Disease
- LY3002813
- Placebo
-
Delray Beach, Florida
- +8 more
Jun 10, 2020
Alzheimer, Dementia Trial in Orlando (Performing Arts Instruction)
Completed
- Alzheimer Disease
- Dementia
- Performing Arts Instruction
-
Orlando, FloridaDr. Phillips Center for the Performing Arts
Feb 18, 2020
Alzheimer Trial in Canada, United States (Placebo Control, ELND005)
Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)
Completed
- Alzheimer Disease
- Crenezumab dose level 1
- +3 more
-
Phoenix, Arizona
- +12 more
Jul 23, 2019
Alzheimer Trial in Japan, United Kingdom, United States (LY3303560 - IV, Placebo - IV, Florbetapir F 18)
Completed
- Alzheimer Disease
- LY3303560 - IV
- +3 more
-
Melbourne, Florida
- +10 more
Jul 2, 2019
Alzheimer Trial in Worldwide (Placebo, BI 409306, Donepezil)
Completed
- Alzheimer Disease
- Placebo
- +2 more
-
Sherman Oaks, California
- +59 more
Oct 18, 2018
Alzheimer Trial in Japan, United States (LY3002813-IV, LY3002183-SC, Placebo-IV)
Completed
- Alzheimer Disease
- LY3002813-IV
- +2 more
-
Long Beach, California
- +5 more
Dec 21, 2017
Alzheimer Trial in Worldwide (bapineuzumab, )
Alzheimer Trial in Worldwide (bapineuzumab, )
Alzheimer Trial in Worldwide (Bapineuzumab 0.5 mg/kg)
Terminated
- Alzheimer Disease
- Bapineuzumab 0.5 mg/kg
-
Birmingham, Alabama
- +182 more
Nov 30, 2015
Alzheimer Trial in United States (PF-04494700 - Low Dose Arm, PF-04494700 - High Dose Arm, Placebo Comparator)
Completed
- Alzheimer Disease
- PF-04494700 - Low Dose Arm
- +2 more
-
Sun City, Arizona
- +11 more
Aug 19, 2009
Alzheimer Trial in Canada, United States (xaliproden (SR57746A))
Completed
- Alzheimer Disease
- xaliproden (SR57746A)
-
Birmingham, Alabama
- +120 more
Aug 20, 2008